目的探讨左半结肠癌并发急性肠梗阻一期切除吻合的合理性与评价。方法回顾性分析我院1994年2月期间至2003年2月采用一期切除吻合术治疗左半结肠癌并发急性肠梗阻64例的临床资料。结果全组患者无死亡及腹腔感染。7例(10.9%)发生切口感染，3例(4.7%)发生吻合口漏，均治愈。住院时间10~36 d，平均16 d。结论部分经选择的病例中开展一期切除吻合术是安全、可行的，选择性应用一期切除吻合术是治疗左半结肠癌并发急性肠梗阻的理想术式。
ObjectiveTo study the protective effects of ischemia preconditioning (IPC) on cryopreservation injury of rat liver.MethodsThe model of isolated nonrecirculated perfusion rat liver was established. The grafts were treated with IPC in different time (ischemia preconditioning time in IPC1 group was 5 min; the time in IPC2 group was 10 min; while the time in IPC3 group was 15 min). The cryopreservation injury of the grafts in each group was determined and compared. ResultsThe levels of aspartate transaminase (AST) and alanine transaminase (ALT) in the effluent solutions in IPC1 group were (40.1±6.3) U/L and （17.1±0.5） U/L respectively, and IPC2 group (53.6±3.7) U/L, （19.7±0.5） U/L, which were much lower than those of nonpreconditioning (NPC) group 〔(64.5±8.2) U/L, （23.8±3.9） U/L〕 (P＜0.05). Those in IPC1 group was much lower than those in IPC2 group and IPC3 group 〔(63.8±7.2) U/L,（22.8±2.5） U/L〕 (P＜0.05). The level of lactic acid dehydrogenase (LDH) in NPC group (104.3±20.6) U/L, IPC1 group (84.1±19.7) U/L, IPC2 group (90.5±21.1) U/L, and IPC3 group (103.1±18.5) U/L were of no significant difference (Pgt;0.05). The contents of bile product and the hepatocellular contents of ATP in IPC1 group were (53.5±10.2) μl and (6.15±0.65) μmol/g respectively, and IPC2 group (41.5±8.1) μl, (4.77±0.21) μmol/g, which were much higher than those NPC group 〔(22.8±9.7) μl, (2.62±0.34) μmol/g〕 (P＜0.05). Those in IPC1 group were much higher than those in IPC2 group and IPC3 group 〔(27.5±2.8) μl, (2.61±0.29) μmol/g〕 (P＜0.05). The contents of malondialdehyde (MDA) in liver tissue in IPC1 group was (4.36±0.26) nmol/gand IPC2 group (5.51±0.13)
目的 探讨原发性空、回肠肿瘤的临床表现、病理类型及其特点，为进一步提高对该类疾病的诊断水平提供临床经验。 方法 对2003年1月－2012年11月62例原发性空、回肠肿瘤患者的临床资料进行回顾性分析。 结果 患者年龄（55 ± 16）岁，＞40岁者占83.9%。良性肿瘤9例，恶性肿瘤53例，良、恶性之比为1︰5.9。53例恶性肿瘤包括恶性间质瘤26例，恶性淋巴瘤15例，腺癌9例，另有平滑肌肉瘤、肉瘤样癌、滤泡树突状细胞肉瘤各1例；主要临床表现为腹痛（44/62，71.0%）、肠梗阻（22/62，35.5%）、贫血（16/62，25.8%）、腹胀不适（11/62，17.7%）、消化道出血（10/62，16.1%）、腹部包块（8/62，12.9%）。术前小肠肿瘤的诊断率仅为25.8%（16/62），46例患者经手术探查及术后病理检查得以确诊。 结论 原发性空、回肠肿瘤缺乏特异性临床表现，早期诊断相当困难，术前误诊率高，高度警惕和加深对该疾病的认识十分重要。
ObjectiveTo observe changing trend of thyroid hormones levels for postoperative patients with differentiated thyroid carcinoma,and to discuss the best therapeutic timing of thyrotropin (TSH) suppression. MethodsNinety-six patients with differentiated thyroid carcinoma from January 2011 to December 2013 in this hospital were selected.All of these 96 cases were divided into total thyroidectomy group (n=50) and thyroid lobectomy and isthmectomy group (n=46) according to the surgical approach.Serum thyroid hormones levels (T3,FT3,T4,FT4,and TSH) were detected on day 1,2,4,5,7,14 after operation. Results① In the total thyroidectomy group,the levels of T3 and FT3 elevated transiently on day 5,then decreased gradually,and which were lower than the low limit of normal range on day 14.The levels of T4 and FT4 elevated transiently,then reached the peak on day 2,and which started to decrease gradually and reached the low limit of normal range on day 14.The value of serum TSH decreased transiently,which started to increase rapidly on day 2 and surpassed the high limit of normal range on day 4,then continued to rise until on day 14.② In the lobectomy and isthmectomy group,the values of T3 and FT3 decreased gradually,then started to rise on day 5,and which were lower than preoperative values until on day 14.The values of T4 and FT4 elevated transiently and which reached the peak on day 2,and then gradually decreased,which appeared to be lower than preoperative values on day 14.The value of TSH decreased transiently,and which started to rise on day 4,then elevated gradually and exceeded preoperative level on day 7,which reached the high limit of normal range on day 14. ConclusionsThere are dynamic changes of thyroid hormones in postoperative patients with differentiated thyroid carcinoma.It is feasible to determine the best therapeutic timing of TSH suppression according to the levels of postoperative thyroid hormones.The best timing of thyrotropin suppression therapy is that TSH is above the high limit of normal range after operation.